IVIG Treatment May Lead to Poorer Outcomes in GBS Patients
A new study shows that individuals treated with intravenous immune globulin (IVIG) for Guillain-Barré syndrome are at increased risk of developing hypoalbuminemia (reduced albumin levels).
Alzheimer’s Could Be Detected Seven Years Prior to Symptoms
A new study shows that brains of people genetically inclined toward Alzheimer’s are likely to show abnormal immune reactions as early as seven years before the expected onset of the disease.
Ebola Symptoms Absent in Some Infected Persons
A recent study shows that people can be infected with the Ebola virus and not show any symptoms.
Reduced Mortality with Use of Four-Factor Prothrombin Complex Concentrates vs. FFP for Warfarin Reversal: Meta-Analysis
The optimal reversal strategy for urgent reversal of warfarin is unclear, but Canadian investigators conducted a systematic review of the clinical literature through December 2015, and identified five randomized clinical trials and eight observational studies for evaluation.
Sunlight Produces Faster T Cells to Boost Immunity
Researchers have found that sunlight’s rays speed up helper and killer T cells in the skin.
Scientists Discover Post-Exposure Treatment with Horse Antibodies Is Effective for Ebola
Researchers in Melbourne have developed an effective, rapid and economical treatment for Ebola using antibodies from horses.
No Link Between Flu or Flu Vaccine and Autism, Study Finds
A new study shows that babies of pregnant women who get the flu or who are vaccinated against the flu do not have an increased risk for Autism Spectrum Disorder.
Topical Use of Fibrin Sealant Can Reduce Blood Loss and Need for Transfusion in Total Knee and Hip Arthroplasty
To assess the safety and effectiveness of topical administration of fibrin sealants on postoperative blood loss and blood requirements in patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA), Chinese investigators searched electronic medical databases through February 2016 to identify randomized clinical trials (RCTs) for inclusion in a meta-analysis.
Infusion of BPX-501 T Cells Renders Haplo-HSCT a First-Line Option for Children with PI
A Phase I/II study indicates that haplo identical hematopoietic stem cell transplantation (haplo-HSCT), after depletion of α/β T cells and B cells followed by adoptive infusion of donorBPX-501 cells, is an effective alternative for children with primary immunodeficiency disease (PI) in need of an urgent allograft or lacking a suitable human leukocyte antigen (HLA)-matched donor.
Study Identifies Why TB Vaccines Are Ineffective
Researchers at the Washington University School of Medicine in St. Louis have discovered the reason the BCG vaccine and investigational vaccine candidates are not more effective.
